Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis

Prazosin an α1-adrenoceptor (AR) antagonist has been shown to reduce liver injury in a mouse model of non-alcoholic steatohepatitis (NASH) and is suggested as a potential treatment of NASH especially given its concomitant anti-fibrotic properties. The effect however, of β-AR blockade in non-cirrhoti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biochem Biophys Res Commun
Päätekijät: McKee, Chad, Soeda, Junpei, Asilmaz, Esra, Sigalla, Barbara, Morgan, Maelle, Sinelli, Nicoletta, Roskams, Tania, Oben, Jude A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226920/
https://ncbi.nlm.nih.gov/pubmed/23850676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2013.07.005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia